DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

The $400 million that the United States Congress removed from a list of programmes from which the Trump administration wants ...

Lenacapavir, a new HIV prevention injection, will offer six months of protection per dose at a cost of Sh6,000, according to ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn't cancel the cuts to global HIV and TB programmes made in February . HIV projects that have ...

PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times.

Last week, the President’s Emergency Plan for AIDS Relief narrowly avoided a $400 million budget cut, thanks to bipartisan support. However, preserving PEPFAR should not be the ultimate goal; global ...

来那帕韦是一种长效针剂，由美国吉利德科学公司研发，于2022年在美国获批，今年1月该药物上市申请被中国药监局批准。每半年打一针，即可近100%地预防HIV。效果很强，价格不菲。 按照每年两针算，年定价为2.8万美元，折合人民币约20万元。

The Midwest AIDS Training and Education Center’s funding will be cut completely in the current budget proposal for fiscal ...